China Healthcare Sector Analysis

Product Code RCS00448
Publication Date October 2009
Publisher RNCOS
Product Type Report
Pages 105

China's healthcare industry is entering into a new era with advance development of the infrastructure system. The industry is blessed with several advantages like large population of the country, increasing ageing population, increasing prevalence of lifestyle disease and many more. The government has also boosted the industry growth by blessing the sector with a US$ 120 Billion reform package. Backed by these all factors, healthcare sector in China is expected to outperform all other sectors in the country in terms of growth.

According to our new analytical study on the sector called China Healthcare Sector Analysis the China healthcare spending is forecast to grow at CAGR of over 18% during 2010-2012. Currently, the market is characterized by major changes in rural healthcare infrastructure. Anticipating the future growth, many private sector giants are looking to invest in the sector to get a pie of the chunk.

Our report has found that medical device market is expected to grow most in all other segments. The government decision to improve the healthcare infrastructure in rural areas will result in increasing demand of medical devices and equipments. Backed by this increasing demand, the medical device market is expected to grow at a CAGR of around 20% during 2010-2012. In this regard, our report provides rational analysis of various factors which will drive this market segment over the forecast period.

It also provides extensive information on Chinese pharma market with the detailed description of traditional Chinese medicines and western medicine market. It also highlights several emerging market trends like medical tourism market, healthcare IT market, telemedicine, etc. The research study gives detailed statistical and analytical review on demographics, macroeconomic indicators, disease profile, healthcare services market, key drivers and restraints. It contains all the vital information that will help clients to draw up their market strategies and assess opportunity areas in China's healthcare market.

  • 1. Analyst View
  • 2. Research Methodology
  • 3. China - A Booming Economy
  • 4. China Healthcare: Towards Phenomenal Growth
    • 4.1 Household Income
    • 4.2 Ageing Population
    • 4.3 Epidemiological Transitions
    • 4.4 Medical Infrastructure
  • 5. Demographics and Patient Profile
    • 5.1 Population Profile
    • 5.2 Healthcare Indicators
    • 5.3 Disease Profile
      • 5.3.1 Chronic Diseases
      • 5.3.2 Infectious Diseases
      • 5.3.3 Injuries
  • 6. Healthcare Expenditure and Financial Analysis
    • 6.1 Expenditure
    • 6.2 System and Financing
    • 6.3 Future Outlook (2010-2012)
  • 7. Health Services Market
    • 7.1 Structure
      • 7.1.1 Health Institutions
        • 7.1.1.1 Grade
        • 7.1.1.2 Ownership
        • 7.1.1.3 Profitability
    • 7.2 Infrastructure and Facilities
      • 7.2.1 Beds
      • 7.2.2 Health Professionals
    • 7.3 Functioning and Utilization
      • 7.3.1 Availing Health Services
      • 7.3.2 Health Services Utilization
        • 7.3.2.1 Inpatients
        • 7.3.2.2 Outpatients
      • 7.3.3 Income and Expenditure
        • 7.3.3.1 Inpatients
        • 7.3.3.2 Outpatients
    • 7.4 Foreign Investment
  • 8. Pharmaceutical Market
    • 8.1 Introduction
    • 8.2 Western Drugs
    • 8.3 Traditional Chinese Medicines
    • 8.4 Imported Drugs Market
    • 8.5 Key Players
    • 8.6 Key Therapy Areas
    • 8.7 Future Outlook (2010-2012)
  • 9. Medical Devices Market
    • 9.1 Introduction
    • 9.2 Market Segmentation
    • 9.3 Import and Export Analysis
    • 9.4 Key Players
    • 9.5 Future Outlook (2010-2012)
  • 10. Administration & Regulation
    • 10.1 Agencies
    • 10.2 Product Approval
    • 10.3 Pricing and Reimbursements
    • 10.4 IPR Protection
  • 11. Emerging Market Trends
    • 11.1 Health Insurance Market
    • 11.2 Healthcare IT Market
    • 11.3 Telemedicine Market
    • 11.4 Medical Tourism Market
  • 12. Industry Roadblocks
    • 12.1 Cost and Coverage Issues
    • 12.2 IP Protection
    • 12.3 Regulatory and Bureaucratic Hurdles
    • 12.4 Financial Disparity
  • List of Figures:
    • Figure 3-1: Nominal GDP (Trillion US$), 2007-2009
    • Figure 3-2: Foreign Direct Investment (Billion US$), 2007 & 2008
    • Figure 3-3: Forecast for Nominal GDP (Trillion US$), 2010-2012
    • Figure 4-1: Middle Class Population (Million), Jan 2005, Jan 2007 & Jan 2012
    • Figure 4-2: Breakup of Households by Income (%), 2008 & 2012
    • Figure 4-3: Personal Disposable Income (US$ per Head), 2006-2012
    • Figure 4-4: Breakup of Consumer Expenditure (%), 2007 & 2012
    • Figure 4-5: Population above 65 Years of Age (Million), 2006-2009
    • Figure 4-6: Forecast for Population above 65 Years of Age (Million), 2010-2012
    • Figure 5-1: Population (Million), 2006-2009
    • Figure 5-2: Forecast for Population (Million), 2010-2012
    • Figure 5-3: Breakup of Population by Age Group (%), 2006-2009
    • Figure 5-4: Forecast for Breakup of Population by Age Group (%), 2010-2012
    • Figure 5-5: Life Expectancy (Years), 2006-2009
    • Figure 5-6: Forecast for Life Expectancy (Years), 2010-2012
    • Figure 5-7: Infant Mortality Rate (per '000 Live Births), 2006-2009
    • Figure 5-8: Forecast for Infant Mortality Rate (per '000 Live Births), 2010-2012
    • Figure 5-9: Breakup of Deaths by Various Causes (%), 2008
    • Figure 5-10: Obese Population (Million), 1992, 2006 & 2012
    • Figure 5-11: Diabetes Patients (Million), 2007 & 2025
    • Figure 5-12: Number of Patients with Hypertension (Million), 1991, 2005 & 2012
    • Figure 5-13: Mode of New HIV/AIDS Transmission (%), 2007
    • Figure 6-1: Healthcare Expenditure (Billion US$), 2006-2009
    • Figure 6-2: Overview of Healthcare System
    • Figure 6-3: Forecast for Healthcare Expenditure (Billion US$), 2010-2012
    • Figure 7-1: Hospital Beds by Various Departments (%), 2008
    • Figure 8-1: Pharmaceutical Market (Billion US$), 2007-2009
    • Figure 8-2: Share of Western Drugs and Traditional Chinese Medicines (%), 2007
    • Figure 8-3: Sources of Western Drugs Purchases (%)
    • Figure 8-4: Western Drugs Market by Type of Drug (%), 2007
    • Figure 8-5: Forecast for Pharmaceutical Market (Billion US$), 2010-2012
    • Figure 9-1: Medical Devices Market (Billion US$), 2007-2009
    • Figure 9-2: Healthcare Equipments and Supplies Market by Segment (%), 2007
    • Figure 9-3: Forecast for Medical Devices Market (Billion US$), 2010-2012
    • Figure 11-1: Health Insurance Premium Income (Billion Yuan), 2007 & 2008
    • Figure 11-2: Healthcare IT Market (Billion Yuan), 2007-2009
    • Figure 11-3: Healthcare Market Segments by IT Solution (%), 2007
  • List of Tables:
    • Table 3-1: Relative Size of Major Economies (2007 & 2050)
    • Table 4-1: Funds and Construction Investment in Healthcare Sector (Million Yuan), 1990 & 1995-2006
    • Table 5-1: Two-week Morbidity Rate of Various Diseases (%), 2008
    • Table 7-1: Health Institutions by Type (Numbers), 2005, 2007 & 2008
    • Table 7-2: Hospitals and Health Centers by Grade (Numbers), 2008
    • Table 7-3: Hospitals by Beds (Numbers), 2005, 2007 & 2008
    • Table 7-4: Health Institutions by Ownership (Numbers), 2005
    • Table 7-5: Health Institutions by Profitability (Numbers), 2008
    • Table 7-6: Beds by Health Institutions (Numbers), 1980, 1990, 2000, 2005, 2007 & 2008
    • Table 7-7: Health Professionals by Type (Numbers), 1980, 1990, 2000, 2005, 2007 & 2008
    • Table 7-8: Health Professionals by Educational Level (%), 2005
    • Table 7-9: Doctors by Various Departments (Numbers), 1990, 2000 & 2005
    • Table 7-10: Patient Visits in Various Health Institutions (Million), 2001-2008
    • Table 7-11: Daily Visits per Doctor in Hospitals (2000, 2005, 2007 & 2008)
    • Table 7-12: Status of Hospitalization (%), 2003 & 2008
    • Table 7-13: Utilization of Beds in Health Institutions (%), 2008
    • Table 7-14: Inpatient in Various Health Institutions ('000), 2001-2008
    • Table 7-15: Daily Inpatient Visits per Doctor in Hospitals (2000, 2005, 2007 & 2008)
    • Table 7-16: Inpatients by Department in General Hospitals ('000), 2008
    • Table 7-17: Percentage of 10 Main Diseases of Inpatients in City Hospitals (ICD-10), 2007 & 2008
    • Table 7-18: Percentage of 10 Main Diseases of Inpatients in Country Hospitals (ICD-10), 2007 & 2008
    • Table 7-19: Outpatients by Department in Hospitals ('000), 2008
    • Table 7-20: Income and Expenditure of Hospitals by Type ('0000 Yuan), 2008
    • Table 7-21: Income and Expenditure of Government Hospitals (2008)
    • Table 7-22: Average Medical Expense per Inpatient in General Hospitals (Yuan), 2000, 2005, 2007 & 2008
    • Table 7-23: Average Medical Expense per Outpatient in General Hospitals (Yuan), 2000, 2005, 2007 & 2008
    • Table 8-1: Import of Western Drugs by Product Type (Billion US$), 2008
    • Table 8-2: Leading Players in Pharmaceutical Market (H1 2006 & H1 2007)
    • Table 8-3: Drug Sales by Therapy Area (%), 2005 & 2006
    • Table 9-1: Medical Devices Export to Top 10 Countries (Million US$), H1 2007
    • Table 9-2: Medical Device Export by Product Type (Million US$), H1 2007
    • Table 9-3: Medical Devices Import by Product Type (Million US$), H1 2007
    • Table 9-4: Top 10 Medical Device Manufacturers by Sales (Million US$), 2003
    • Table 10-1: Ministry-level Agencies with Health Authority
    • Table 11-1: Population Covered by Urban and Rural Health Insurance Schemes (Million), 1999, 2004, 2007 & 2010

Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)

PRINT/CD-ROM:Despatched within 2 to 4 working days.

Actions

© 2010 | Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85

comodo ev ssl site
Internet shopping is safe
SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment